ArticleBMC public health2026
Epidemiology of cataract in China from 1990 to 2021: findings from the Global Burden of disease study 2021.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyze the burden of cataract in China from 1990 to 2021.
methodUsing the data of the 2021 Global Burden of Disease (GBD 2021) study, analyzed the the prevalence and year lived with disability (YLD) of cataract.
resultsIn 2021, the number of cataract cases in China was 19,784,671(16,950,247 ~ 22,757,901), which increased by 248.08% compared to that in 1990. The YLD caused by cataract were 1,111,945(798,050 ~ 1,510,433) person-year, which increased by 144.62%. The age-standardized prevalence rate showed an upward trend, but the age-standardized YLD rate showed a downward trend in China (P < 0.05). The age-standardized prevalence rate increased from 878.30/100,000 in 1990 to 989.59/100,000 in 2021, with an increase of 12.67%, and average annual percentage change (AAPC) = 0.5%, 95% confidence interval (CI): 0.2%～0.7%, t value: 3.4, and P < 0.05. And the age-standardized YLD rate decreased from 66.97/100,000 in 1990 to 55.89/100,000 in 2021, with a decrease of 16.54%, and AAPC = -0.4%, 95% CI: -0.7%～-0.2%, t value: -3.3, and P < 0.05. And the age-standardized prevalence rate and age-standardized YLD rate of cataract in females were higher than those in males. With the increase of age, the prevalence rate and YLD rate of cataract in both males and females increased. Compared with 1990, the total number of prevalence due to cataract in China in 2021 increased by 248.08%, of which the increase in prevalence rate accounted for 44.56%, population growth accounted for 20.93%, and population aging accounted for 182.59%.
conclusionFrom 1990 to 2021, the number of prevalence and YLD for cataract increased by year, the age-standardized prevalence rate showed an upward trend, and the age-standardized YLD rate showed a downward trend in China. The burden of cataract was higher in females than that in males. With the increase of age, the burden of cataract was gradually increasing.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.